Welcome and Overview David A. Wyman, MPA President, The Rogosin Institute Jeffrey Silberzweig, MD Chief Medical Officer, The Rogosin Institute Associate Professor of Clinical Medicine, Weill Cornell Medicine

The Importance of Genetic Kidney Disease to Patients Glenda Roberts, Director of Communications, The Kidney Precision Medicine Project, Director of Communications and Patient Engagement, Mount Sinai Center for Kidney Innovation

Genetics of Kidney Regeneration Leif Oxburgh, DVM, PhD Scientific Director & VP for Basic & Clinical Research, The Rogosin Institute

Implementation of Genomics and Point of Care Genetics into Clinical Practice, Jordan Nestor, MD, Assistant Professor of Medicine, Columbia University Vagelos College of Physicians and Surgeons

APOL1: A Genetic Determinant of Kidney Disease Barry Freedman, MD, Wake Forest University School of Medicine

Panel Discussion: Speakers and Audience Q&A MODERATOR: Jeffrey Silberzweig, MD Chief Medical Officer, The Rogosin Institute Associate Professor of Clinical Medicine, Weill Cornell Medicine